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Abstract 
Purpose: To develop bioadhesive tablets of diltiazem hydrochloride with a unique combination of 
bioadhesion and drug release. 
Method: Tablets were prepared by physical blending of diltiazem hydrochloride with two polymers, viz., 
carbopol and hydroxylpropyl methyl cellulose in different ratio along with other excipients. A 32 central 
composite design was employed to optimize the formulations on the basis of phycochemical properties, 
bioadhesive strength (measured as force of detachment from gastric mucosa) and in vitro drug release. 
HPMC K 4M and Carbopol 934P were taken as the independent variables. Contour plots were drawn 
and optimum formulations were selected by feasibility and grid searches.  
Results: The tablets showed excellent bioadhesive strength which varied from 7.6 to 21 g. Both 
polymers had effect on the bioadhesive strength of the tablets and maximum bioadhesion was observed 
at the highest level of both the polymers. The drug release from the formulation varied from 79.74 to 
94.54 % in 12 h. The diffusion exponent (n) of Korsmeyer-Peppas model ranged from 0.491 to 0.658 
which indicates the mechanism of drug release was anomalous transport; the diffusion exponent (n) 
increased with increase in the amount of either polymer in the bioadhesive tablet. 
Conclusion: Floating bioadhesive tablets of diltiazem hydrochloride with good bioadhesion and 
controlled release characteristics is feasible. 
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Diltiazem hydrochloride (DTZ) is a calcium 
channel blocker belonging to the 
benzothiazepine family. It is widely prescribed for 
the treatment of hypertension and angina. It has 
an elimination half-life of 3.5 h and an absorption 
zone from the upper intestinal tract. Efficacy of 
the administered dose may get diminished due 
to incomplete drug release from the device 
above the absorption zone. DTZ requires 
multiple daily drug dosage in order to maintain 
adequate plasma concentrations [1]. A suitable 
drug delivery system can improve controlled 
delivery of a drug exhibiting an absorption 
window by continuously releasing the drug for a 
prolonged period before it reaches the 
absorption site, thus ensuring its optimal 
bioavailability [2,3].  
 
Various approaches including floating systems, 
bioadhesive systems, swelling and expanding 
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systems and high density systems have been 
successfully employed to improve the gastric 
residence time of a delivery system [4,5]. 
Though highly efficient for gastroretention, 
floating systems suffer from a major 
disadvantage that they are effective only when 
the fluid level in the stomach is sufficiently high. 
However, as the stomach empties and the tablet 
is at the pylorus, the buoyancy of the dosage 
form may be impeded [6]. This serious limitation 
can be overcome by making the system 
eventually adhere to the mucous lining of the 
stomach wall.  
 
Mucoadhesion has been an extensively adapted 
approach for achieving site-specific drug delivery 
through the amalgamation of mucoadhesive 
polymers within pharmaceutical formulations 
along with the active pharmaceutical ingredient 
(API). Mucoadhesive materials are hydrophilic 
macromolecules containing numerous hydrogen 
bond forming groups. The mechanism by which 
mucoadhesion takes place has been said to be 
in two stages: the contact (wetting) stage 
followed by the consolidation stage 
(establishment of adhesive interactions) [7]. 
 
The objective of the current study was to develop 
bioadhesive tablets of diltiazem hydrochloride 
and optimize their bioadhesive and drug release 
characteristics using the benefits of central 






Diltiazem hydrochloride, Carbopol 934P and 
HPMC K4M were obtained as gifts from Modi 
Mudi Pharmaceuticals, Meerut and all other 
chemicals used were of analytical grade. 
 
Preparation of Bioadhesive Tablets 
 
Different bioadhesive tablet formulations of 
diltiazem hydrochloride were formulated using 
varying amount of two polymers (carbopol and 
HPMC) and Microcrystalline cellulose as diluent, 
which does not interfere with the floating 
property of the tablets due to its low bulk density 
[9] along with fixed quantity of talc and 
magnesium stearate as glidant and lubricant 
respectively. All ingredients, except magnesium 
stearate, were passed through 200 µ aperture 
sieve and then mixed for 20 min. Finally, 
Magnesium stearate was added into powder 
blend as a lubricant and mixed for an additional 
3 min before compaction process. Then, 360 mg 
tablets containing 90 mg diltiazem hydrochloride 
were prepared by a lab press [8]. The tablet 
formulations are shown in Table 1. 
 




Diltiazem Hydrochloride 90 mg 
Carbopol 934P 60-100 mg 
HPMC K4M 90-150 mg 
Magnesium stearate 1% 
Talc 3% 




A central composite design (CCD) for two factors 
at three levels each (α = 1) was selected to 
optimize the varied response variables. The two 
factors, viz., polymer X1 (CP) and polymer X2 
(HPMC) of each polymer bland, were varied as 
required by the experimental design and the 
factor level were suitably coded (Table 2). The 
extent of drug release in 12 h (Q12), time to 
release 60 % (t60%) and bioadhesive strength 
(BS) were taken as responsive variables [10]. 
 
Table 2: Factor combination as per central composite 
design 
 
    Formulation 
     no.    
Trial 
no.                
              X1 X2 
Coded factor 
F1 1 -1   -1 
F2 2 -1   0 
 F3 3 -1   +1 
 F4 4  0   -1 
 F5 5  0     0 
 F6 6  0   +1 
 F7 7 +1    -1 
 F8 8 +1    0  
 F9 9 +1  +1 
 
 
Translation of coded levels in actual units 
 
Coded level -1 0 +1 
X1: Carbopol 934P (mg) 60 80 100 
X2: HPMC (mg) 90 120 150 
 
Physical characterization of diltiazem tablets 
 
The formulated tablets were subjected to the 
following physical characterization studies. The 
drug content of each batch of the formulated 
tablets was determined in triplicate by UV–visible 
method at 237nm. The weight variation was 
determined based on 20 tablets using electronic 
balance. Mean tablet hardness was determined 
on six tablets from each batch using Monsanto 
tablet hardness tester. Friability was determined 
(n = 10) using Roche friabilator for 5 min at 25 
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rpm, while thickness was determined using 
vernier calipers. 
 
Measurement of bioadhesive strength of 
tablets 
 
Gastric mucosa of goat was used as the model 
membrane for ex vivo measurement of 
bioadhesive strength. The mucosal membrane 
was excised by removing the underlining 
connective tissues. The mucosa was tied on the 
slide and the slide was fixed in the petri plate 
filled with distilled water and the petri plate was 
placed inside the left arm of the physical 
balance. The tablet was fixed on the left pan of 
the physical balance. The left arm was lowered 
until a tablet contact with the membrane was 
made. A contact force of 10 g was placed on the 
left arm for 5 min. After 5 min, the weight was 
removed from the left pan and the assembly was 
kept undisturbed. Weight was slowly added on 
the right hand side pan until the tablet just got 
detached from the membrane surface. The peak 
detachment force was recorded as a measure of 




Tablets were weighed (W1) individually and 
placed in a USP XXII paddle method (apparatus 
2) (model DS 8000, Lab India) containing 900 ml 
0.1N HCl, stirred at 50 rpm and maintained at 37 
± 0.5 °C. At regular intervals, the tablets were 
removed from the dissolution apparatus, excess 
water removed carefully using filter paper and re-
weighed (W2). Swelling index (S) of each tablet 
was calculated by using following formula [12]: 
 
S = (W2 – W1)/W1  …………………… (1) 
 
In vitro drug release studies 
 
Dissolution studies were carried out on all the 
tablet formulations in triplicate, employing USP 
XXII paddle method (Apparatus 2) at 50 rpm and 
37 ± 0.5 °C, using 900 ml simulated gastric fluid 
(SGF) pH 1.2 without pepsin as the dissolution 
medium. Five ml of sample was withdrawn 
periodically at suitable time intervals and 
replaced with an equivalent volume of fresh 
dissolution medium. The withdrawn samples 
were analyzed by UV Spectrophotometer (UV 
1800 Shimadzu) at 237 nm. Drug release data 
obtained were analyzed using Zorel software 
[13] which has in-built provisions for applying the 
correction factor for volume and drug losses 
during sampling [14].  
 
The drug release data were fitted to 
Korsemeyer-Peppas model (Eq 2) [15].  
Mt / M∞ = k1 t n + k2 t 2n   ……………………… (2) 
   
where, Mt is amount of drug released at time ‘t’, 
M∞ is amount of drug released at an infinite time, 
k1 is the magnitudinal contribution of diffusion 
mechanism, k2 is the magnitudinal contribution of 
polymer relaxation mechanism, and n is the 
Fickian diffusion coefficient.  
 
Based on phenomenological analysis, the type of 
release (i.e., whether Fickian, non-Fickian 
(anomalous) or zero order) was predicted [11]. 
t60% value was calculated using Stineman 
interpolation option of the Graph 2.0 software 
(M/s Micromath Inc, St Louis, USA). 
 
Optimization data analysis and validation of 
optimization model 
 
The response variables which were considered 
for systematic optimization included t60%, Q12 
and BS. For the studied design, multiple linear 
regression analysis (MLRA) method was applied 
to fit full second-order polynomial equation with 
added interaction terms to correlate the studied 
responses with the examined variables using 
Design expert software version 8.0.5 (Stat-Ease, 
USA 45days trial version). The polynomial 
regression results were demonstrated for the 
studied responses. Finally, the prognosis of 
optimum formulation was conducted using a two-
stage brute force technique using MS-Excel 
spreadsheet software. First, a feasible space 
was located and second, an exhaustive grid 
search was conducted to predict the possible 
solutions. Six formulations were selected as the 
confirmatory check-points to validate RSM. The 
observed and predicted responses were critically 
compared. Linear correlation plots were 
constructed for the chosen eight optimized 
formulations. The residual graphs between 
predicted and observed responses were also 
constructed separately, and the percent bias (= 
prediction error) was calculated with respect to 




Physicochemical characteristics of the 
tablets 
 
Physical appearance, tablet hardness, friability, 
weight variation, and drug content uniformity of 
all formulations were satisfactory, as shown in 
Tables 3. It was observed that all the tablets 
showed acceptable physicochemical properties.   
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Mean friability (%) Drug content 
(%) 
F1     4.5 ±  0.051 360.4 ± 1.26 0.65 98.53 
F2    4.5 ± 0.054 361.5 ± 1.69 0.68 98.38 
F3    4.6 ± 0.083 361.0 ± 1.07 0.64 98.46 
F4    4.4 ± 0.054 359.5 ± 1.70 0.56 99.42 
F5 4.6 ±0.10 360.5 ± 0.99 0.58 99.78 
F6  4.5 ± 0.12 360.0 ± 1.15 0.68 97.32 
F7  4.6 ± 0.10 359.5 ± 1.13 0.69 100.52 
F8  4.8 ±0.081 360.8 ± 1.10 0.45 99.02 
F9  4.7 ±0.136 359.5 ± 1.35 0.46 101.56 




N K k1 k2 Rel12 hrs 
(%) 
t60% Drug rel rate 
(mg/h) 
F1 0.4911 0.2590 1.2895 0.0132 94.54 4.95 8.298 
F2 0.5049 0.2539 1.2863 0.0147 91.04 4.66 8.047 
F3 0.5153 0.2452 1.2715 0.0177 90.79 4.75 7.875 
F4 0.5154 0.2397 1.2629 0.0178 87.60 5.19 7.764 
F5 0.5409 0.2198 1.2310 0.0240 86.25 5.16 7.397 
F6 0.5884 0.1876 1.1788 0.0351 84.86 5.81 6.880 
F7 0.6189 0.1621 1.1346 0.0426 84.56 7.14 6.396 
F8 0.6333 0.1519 1.1195 0.0445 82.39 7.66 6.177 
F9 0.6585 0.1417 1.1041 0.0489 79.74 7.78 6.046 
 
Bioadhesive strength of tablets 
 
The bioadhesive strength of the tablets ranged 
between 7.6 to 21 g, and increased with increase 
in the concentration of the polymer in the tablet; 




Fig 1: Bioadhesive strength of the formulations. Note: 
F1 – F9 are as defined in Table 1.   
 
In vitro drug release  
 
Table 4 enlists various dissolution parameters 
calculated for all the bioadhesive tablets. The 
value of diffusion exponent (n) showed an 
increasing trend with increase in the content of 
either polymer. The values of Fickian diffusion 
constant (k1) varied between 1.104 and 1.289, 
while those of polymer relaxation constant (k2) 
varied between 0.0132 and 0.0489. The values 
of Q12h ranged between 79.74 and 94.54%. An 
almost linear descending trend was observed in 
Q12h with an increase in CP 934P or HPMC 
fraction.  
 
Response surface analysis 
 
The coefficient of the polynomial equation (Eq 2) 
generated using MLRA for Q12h, t60% and BS of 
the tablet, formed excellent fits to the data, with 
quite high value of r2 ranging between 0.9898 
and 0.999.  
 
Y= β0 + β1 X1 + β2 X2 + β3 X1X2 + β4 X12 +  β5 X22 + 
β6 X1X22+ β7 X12X2   -------------------    (3) 
  
Seven coefficients (β1 to β7) were calculated 
representing β0 as intercept, and β3 to β7 various 
quadratic and interaction terms. 
 
Figs 2 to 4 show the various three dimensional 
response surface plots for the studied response 
properties, viz, t60%, Q12, and BS. Fig 2 Showed a 
linear increasing trends in the value of t60% with 
increase in the amount of either polymer but the 
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influence of CP wass more significant than 
HPMC, indicating that the former has better 
release controlling properties than the latter. 
Hence, the higher levels of CP have to be 
complemented with lower levels of HPMC and 
vice-versa to maintain the value of t60% at a 
constant level.  
 
Fig 2: Response surface plot showing the influence of 
CP and HPMC on the value of t60% of bioadhesive 
tablets of diltiazem hydrochloride. 
 
Fig 3 shows a decline in the value of Q12 with an 
increase in the concentration of each polymer. 
Nonlinear descending lines elucidate that the 
variation in Q12 is a function of polymer levels, 
the effect of HPMC being less significant. 
       
Fig 3: Response surface plot showing the influence of 
CP and HPMC on the value of Q12 of  bioadhesive 
tablets 
 
Fig 4: Response surface plot showing the influence of 
CP and HPMC on the value of bioadhesive strength of 
bioadhesive tablets of diltiazem hydrochloride. 
 
Fig. 4 shows nearly linear ascending pattern for 
the values of bioadhesive strength as the content 
of either polymer increased in the formulation 
and the effect of CP is more prominent than 
HPMC. The maximum bioadhesive strength was 
observed at the highest levels of both the 
polymers. The results are in consonance with 
literature reports stating high contribution of 
carbomers in attainment of bioadhesive strength 
in hydrophillic matrices [10]. 
 
Selection of optimized formulation 
 
The optimum formulation was selected by 
trading off various response variables and 
adopting the following maximizing criteria: t60% > 
5.0 h, Q12 > 88%, BS > 12. Upon comprehensive 
evaluation of grid searches, the formulation (CP 
84 mg, HPMC 90 mg) fulfilled the optimal criteria 
of best regulation of the release rate and 
bioadhesive characteristics with t60% of 5.33 h, 
Q12h of 90.95 % and bioadhesive strength of 
12.79 g. Thus, besides controlling drug release, 
the formulation has definite gastroretentive 
potential to retain the drug in the gastric 
environment and upper part of intestine. 
 
Validation of response surface methodology 
results  
 
Linear correlation plots drawn between predicted 
and observed responses, also demonstrated the 
high value of r, in the range of 0.991 - 0.987 
indicating excellent fit. Upon comparison of the 
observed responses with those of anticipated 





The present investigation describes the 
development of an optimized gastric bioadhesive 
tablet formulation of diltiazem hydrochloride. A 
combination of ionic polymer (such as CP) and 
nonionic polymer (such as HPMC) were choosen 
because they are known to provide a formulation 
with controlled drug release and/or desired 
mucoadhesive properties [17]. 
 
Bioadhesive strength increased with increase in 
the content of either polymer, an observation that 
has previously been made [16]. Hydrogels are 
known to swell readily on contact with the 
hydrated mucous membrane [17]. Water sorption 
reduces glass transition temperature below 
ambient conditions, and hydrogels become 
progressively rubbery due to uncoiling of 
polymer chains and subsequent increased 
mobility of the polymer chains. The glass-
rubbery transition provides hydrogel 
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plasticization, resulting in a large adhesive 
surface for maximum contact with mucin and 
flexibility to the polymer chain for interpenetration 
with mucin. Increasing the polymer amount may 
provide more adhesive sites and polymer chains 
for interpenetration with mucin, resulting in 
augmentation of bioadhesive strength. Although 
the maximum value of bioadhesive strength was 
attained at higher levels of both polymers and 
the effect carbopol on the bioadhesion was 
distinctly more pronounced than that of HPMC. 
The swelling of the formulation increased as the 
amount of either polymer increase in the tablet 
but the effect of HPMC on the swelling was more 
pronounced than that of carbopol due to the 
hydrophilic nature of the former. 
 
The bioadhesive tablets showed values of n 
ranging between 0.4911 and 0.6585, indicating 
the non-Fickian release behaviour of all 
formulations. The values of n showed increasing 
trend with increase in HPMC content, even at 
higher levels of Carbopol. on the other hand, the 
kinetic constant, k, showed a decline with 
increase in the content of either polymer. 
Relatively much higher magnitude of Fickian 
diffusion constant, k1 vis-à-vis the polymer 
relaxation constant, k2 clearly showed that drug 
release was predominantly determined by 
Fickian diffusion, with a negligible contribution of 
polymer relaxation. This is in agreement with 
earlier findings that a mixture of HPMC and 
Carbopol resulted in the reduction of polymer 
viscosity due to reduced hydration [11,18].  
 
This reduction of viscosity could facilitate drug 
diffusion through polymer hydrogel. The overall 
rate of drug release tended to decrease with 
increase in the concentration of either HPMC or 
carbopol. Similarly, the values of Q12h decreased 
with increase in polymer content. However, the 
values of t60% increased from 4.95 to 7.78 h for 
both polymers. 
 
In Central Composite Design (CCD), all the 
factors are studied for all plausible combinations, 
as it is considered to be most efficient in 
estimating the influence of individual variables 
and their interactions, using minimum 
experimentation. Hence, CCD for two factors at 
three levels with a = 1 was chosen. The high 
values of r2 exhibited by the polynomial 
relationships vouched high statistical validity (p < 
0.001) of Equation 2 for fitting to the 
experimental data. The amounts of CP and 
HPMC had a positive influence on the values of 
coefficients of t60%, the effect being more 
apparent with HPMC. On the other hand, the 
positive effect of CP is vividly far more 
pronounced than that of HPMC in regulating the 




Suitable balancing between the levels of the two 
polymers (CP and HPMC) is imperative to 
attaining maximum prolongation of drug release 
and adequate bioadhesive strength. The 
bioadhesive nature of the formulation may 
prolong gastrointestinal (GI)  residence time thus 
ensuring maximum absorption. The optimized 
formulation showed good controlled release and 
bioadhesive characteristics indicating the 
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